# High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission

> **NCT00002567** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 45 (estimated)

## Conditions studied

- Bone Marrow Ablation
- Leukemia

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** etoposide
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** low-LET electron therapy
- **RADIATION:** low-LET photon therapy

## Key facts

- **NCT ID:** NCT00002567
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-03
- **Primary completion:** 2000-11
- **Final completion:** 2000-11
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2013-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002567, "High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00002567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*